The Rising Prevalence Of Neurological Disorders Is Fueling The Growth Of The Market Due To Environmental Toxins And Increasing Global Disease Burden: Powering Innovation and Expansion in the Neuroregeneration Therapy Market by 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Neuroregeneration Therapy Market Through 2025?
In recent times, the neuroregeneration therapy market has witnessed a swift growth. There is a predicted jump from $9.98 billion in 2024 to $11.29 billion in 2025, which represents a compound annual growth rate (CAGR) of 13.1%. This notable growth during the historical period can be ascribed to various factors such as the rising incidence of neurological disorders, an increasing global elderly population, escalated investments in research and development, enhanced government backing and funding, and the growing alliances between academic institutions and the industry.

What's the Projected Size of the Global Neuroregeneration Therapy Market by 2029?
Acceleration in the growth of the neuroregeneration therapy market size is projected in the upcoming years, expected to reach $18.23 billion by 2029 with a compound annual growth rate (CAGR) of 12.7%. The escalation during the forecast period can be connected to an upswing in the demand for neuroregeneration therapies and cell therapies, a surge in healthcare needs, augmented investment in biotechnology and an increase in the aging population. Key trends during the forecast period encompass advancements in stem cell-based therapies, the emergence of personalized medicine, breakthroughs in gene editing for neurodegenerative diseases, the application of nanotechnology in drug delivery, and the evolution of pharma-biotech.

View the full report here:
https://www.thebusinessresearchcompany.com/report/neuroregeneration-therapy-global-market-report

Top Growth Drivers in the Neuroregeneration Therapy Industry: What's Accelerating the Market?
An upward trajectory in the incidence of neurological disorders is anticipated to facilitate the expansion of the neuroregeneration therapy market. Neurological disorders encompass conditions affecting the brain, spinal cord, and peripheral nerves, leading to a disruption of ordinary nervous system functions. This escalation in neurological disorders can be attributed to environmental toxins, since prolonged exposure to harmful pollutants like heavy metals, pesticides, and industrial chemicals can create irreparable damage to the nervous system, thereby increasing the likelihood of neurological diseases. With its set goal to repair or replace impaired neurons and tissues, neuroregeneration therapy addresses these disorders by rejuvenating the lost functions, encouraging healing in the brain, spinal cord, or nerves which in turn enhances mobility, sensation, and overall life quality. For example, the World Federation of Neurology, a UK-based association of national neurological societies, reported in October 2023, that over 40% of the worldwide population is presently grappling with some kind of neurological condition, with predictions suggesting this number to almost double by the year 2050. Hence, the escalating incidence of neurological disorders is fueling the growth of the neuroregeneration therapy market. There is an impending surge in the aging population, which will likely accelerate the growth of the neuroregeneration therapy market. 'Aging population' denotes a demographic shift towards a larger fraction of elderly individuals in society, leading to possible social and economic ramifications. The growth in the aging population can be traced back to increased life expectancy, achieved through improved healthcare and living standards, resulting in a larger number of elderly individuals. Through its ability to repair damaged nerve cells and enhance brain functionality and mobility, all while decelerating cognitive deterioration, neuroregeneration therapy benefits the aging population suffering from neurological conditions. Specifically, the House of Commons Library, a UK-based information resource of the lower house of the British Parliament, disclosed in July 2024, that in 2022, the section of the population aged 65 and above made up around 19% of the UK's total population, equating to approximately 12.7 million people. This segment is predicted to see a significant growth surge, expected to reach 22.1 million and comprising 27% of the population by the year 2072. Thus, the mounting aging population is propelling the expansion of the neuroregeneration therapy market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27358&type=smp

What Are the Key Trends Driving Neuroregeneration Therapy Market Growth?
Key firms in the neuroregeneration therapy sector are aiming to improve nerve regeneration by focusing on the production of advanced goods such as resorbable implants that assist axonal growth and enhance peripheral nerve repair procedures. Resorbable implants are medical devices that dissolve over time and are absorbed by the body after they have performed their intended function, negating the need for surgical extraction. A prime example of this is the launch of the NeuraGen 3D Nerve Guide Matrix by Integra LifeSciences Holdings Corporation, a US-based biotech company, in March 2022. This product, specifically designed for the repair of peripheral nerve discontinuities, combines Integra's type 1 bovine collagen with an innovative internal matrix featuring porous channels. These guide the migration of Schwann cells and direct axonal growth, providing an optimal environment for nerve healing. This new product marks a significant milestone in peripheral nerve repair, providing a novel solution for surgeons dealing with short to mid-gap nerve repairs. It is the result of years of research and technological collaboration, all with the goal of enhancing patient recovery following nerve injuries.

What Are the Main Segments in the Neuroregeneration Therapy Market?
The neuroregeneration therapy market covered in this report is segmented

1) By Type Of Neuroregeneration Therapy: Stem Cell Therapy, Gene Therapy, Pharmacological Therapy, Neurostimulation Therapy, Other Types Of Neuroregeneration Therapy
2) By Technology: Tissue Engineering, Cranial And Spinal Stimulation, Nanotechnology In Drug Delivery, Biomaterials Development
3) By Mode Of Administration: Oral, Injectable, Implantable, Other Modes Of Administration
4) By Indication: Spinal Cord Injury, Traumatic Brain Injury, Stroke, Parkinson's Disease, Multiple Sclerosis, Alzheimer's Disease, Peripheral Nerve Injury, Other Indications
5) By End-User: Hospitals, Clinical Research Institutes, Academic Institutions, Pharmaceutical And Biotechnology Companies

Subsegment:
1) By Stem Cell Therapy: Embryonic Stem Cell Therapy, Mesenchymal Stem Cell Therapy, Neural Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy, Hematopoietic Stem Cell Therapy
2) By Gene Therapy: In Vivo Gene Therapy, Ex Vivo Gene Therapy, Viral Vector Based Gene Therapy, Non Viral Vector Based Gene Therapy, Genome Editing Gene Therapy
3) By Pharmacological Therapy: Neuroprotective Drugs, Neurotrophic Factor Based Drugs, Anti Inflammatory Drugs, Antioxidant Drugs, Cholinesterase Inhibitors
4) By Neurostimulation Therapy: Deep Brain Stimulation, Transcranial Magnetic Stimulation, Vagus Nerve Stimulation, Spinal Cord Stimulation, Transcranial Direct Current Stimulation
5) By Other Types Of Neuroregeneration Therapy: Nanotechnology Based Therapy, Exosome Based Therapy, Biomaterial Based Therapy, Electromagnetic Field Therapy, Hyperbaric Oxygen Therapy

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=27358&type=smp

Which Top Companies are Driving Growth in the Neuroregeneration Therapy Market?
Major companies operating in the neuroregeneration therapy market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Sanofi S.A., AstraZeneca PLC, Novartis International AG, Stryker Corporation, Biogen Inc., Synovis Life Technologies Inc., Integra LifeSciences Holdings Corporation, AxoGen Inc., Denali Therapeutics Inc., Aspen Neuroscience Inc., Neurona Therapeutics Inc., Lineage Cell Therapeutics Inc., Checkpoint Surgical Inc., Stemedica Cell Technologies Inc., Polyganics B.V., Epineuron Technologies Inc., NeuExcell Therapeutics Inc.

Which Regions Will Dominate the Neuroregeneration Therapy Market Through 2029?
North America was the largest region in the neuroregeneration therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neuroregeneration therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=27358

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay,
Americas: +1 310-496-7795,
Asia: +44 7882 955267 & +91 8897263534,
Europe: +44 7882 955267,
Email: saumyas@tbrc.info

The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.